Therapeutic Targeting of Long Non-Coding RNAs in Cancer

540Citations
Citations of this article
423Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Long non-coding RNAs (lncRNAs) represent a significant population of the human transcriptome. Many lncRNAs exhibit cell- and/or tissue/tumor-specific expression, making them excellent candidates for therapeutic applications. In this review we discuss examples of lncRNAs that demonstrate the diversity of their function in various cancer types. We also discuss recent advances in nucleic acid drug development with a focus on oligonucleotide-based therapies as a novel approach to inhibit tumor progression. The increased success rates of nucleic acid therapeutics provide an outstanding opportunity to explore lncRNAs as viable therapeutic targets to combat various aspects of cancer progression.

Cite

CITATION STYLE

APA

Arun, G., Diermeier, S. D., & Spector, D. L. (2018, March 1). Therapeutic Targeting of Long Non-Coding RNAs in Cancer. Trends in Molecular Medicine. Elsevier Ltd. https://doi.org/10.1016/j.molmed.2018.01.001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free